This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series
Menu

David Bienvenue, PhD
Senior Director, Protein Sciences at Aptevo Therapeutics
Speaker

Profile

Dr. Bienvenue is currently a Senior Director at Aptevo Therapeutics, where he manages the Protein Sciences group and leads the Early Product Development (EPD) team. His team focuses on the stability and manufacturability of ADAPTIR bispecific proteins to identify lead clinical candidates.

At this event

Prev
Next
H.Kaspar Binz, Ph.D.
Vice President and Co-Founder
Molecular Partners AG

See David at Antibody Engineering & Therapeutics Series